Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Health Care. Both BBP and LFSC have the same Total Expense Ratio (TER) of 0.79%. BBP is up 5.62% year-to-date (YTD) with +$4M in YTD flows. LFSC performs worse with -7.57% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of BBP and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP LFSC | +2.73%-5.12% | +7.35%-13.36% | +5.62%-7.57% | +41.19%+48.56% | +72.79%n/a | +54.18%n/a |
| Flows | BBP LFSC | +$4M+$6M | +$16M+$6M | +$4M+$5M | +$19M+$16M | +$19M- | +$9M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP LFSC | +24.64%+22.88% | +25.49%+28.76% | +23.37%n/a | +26.10%n/a |
| Max drawdown | BBP LFSC | -7.42%-13.77% | -17.97%-19.03% | -25.54%n/a | -38.24%n/a |
| Max drawdown duration | BBP LFSC | 32d77d | 106d70d | 292dn/a | 915dn/a |
BBP | LFSC | |
Last sale 3/13/2026 at 1:30 PM | $81.25 | $33.61 |
| Previous close 03/12/2026 | $81.68 | $33.82 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | LFSC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | LFSC | |
|---|---|---|
| Last price | $81.25 | $33.61 |
| 1D performance | -0.53% | -0.62% |
| AuM | $50.55 M | $90.59 M |
| E/R | 0.79% | 0.79% |
BBP | LFSC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Emerald Group |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 58 | 34 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | October 31, 2024 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.